Search

Abstract Introduction Neuromuscular diseases (NMDs) entail a group of mostly inherited genetic disorders with heterogeneous phenotypes impacting muscles, the central or peripheral nervous system. They can lead to severe disabilities and shortened lifespans. Despite their severity, NMDs often lack in public awareness and appropriate medical and social support. Telemedicine can improve patients’ and caregivers’ lives by enhancing continuity of and access to care. The first aim of this systematic review was to summarise the status quo of telemedicine services for patients with NMDs. Secondly, barriers and facilitators of the respective implementation processes should be analysed. Methods The databases PubMed, Web of Science and CENTRAL by Cochrane were searched in May 2022. To be truly explorative, any original evidence from any setting was included. Two independent researchers completed the screening process. Data was extracted and analysed using the taxonomy of Bashshur et al. (2011) and the Consolidated Framework for Implementation Research (CFIR). Results Fifty-seven original papers were included in the systematic review. The results showed a high representation of teleconsultations and remote monitoring studies. Teleconsultations replaced in person appointments and telemonitoring mostly focused on ventilation. Physical therapy, pulmonology, neurology, and psychology were the most represented medical specialties. We found barriers and facilitators relating to implementation mainly referred to the intervention and the individuals involved. Technical errors and inaccessibility due to a lack of technical devices or the patient’s disability were stated as hindrances. A positive mindset of users as well as patient empowerment were necessary for the adoption of new technology. Technophobia or uncertainty around technology negatively impacted the implementation process. Discussion This systematic review provides an overview of the current use of telemedicine in patients with NMDs. The distribution of telemedicine interventions between the defined domains was very heterogenous. Previous research has neglected to fully describe the implementation process of telemedicine for NMDs. Conclusion The evidence shows that telemedicine can benefit patients with NMDs in a multitude of ways. Therefore, health policies should endorse and incentivise the uptake of telemedicine by institutions and health care workers. Further research needs to be conducted to confirm the current evidence and close existing research gaps.

Introduction Telehealth service provision and uptake has rapidly increased since the COVID-19 pandemic, allowing healthcare to be delivered safely and reducing non-essential face-to-face (F2F) contact. In Australia, the expansion of subsidisation of telehealth during COVID has led to its permanent installation within Australian primary care in 2022. However, little is known about consumer preferences and experiences with these services, particularly in relation to allied health practice (AHP). Previous studies on telehealth services have focused on general practice rather than allied health (AH) and broader primary care. Given that AH professionals make up a large proportion of the Australian healthcare workforce, the purpose of this study is to explore consumer preferences and experiences with telehealth AHP healthcare.Methods and analysis This study uses a mixed methods research design that incorporates three independent but interrelated phases. Phase 2 of the study will use a focus group methodology to discuss consumer attitudes and experiences via a semistructured interview format. Phase 3 involves a discrete choice experiment (DCE) involving a large online survey conducted across the general population. The DCE will be informed by the qualitative findings from phases 1 and 2. The experiment aims to elicit consumer preferences in relation to AH services delivered through telehealth or F2F consultations, based on several hypothetical scenarios and preferences over several different dimensions.Ethics and dissemination Ethics approval has been obtained from La Trobe University (approval number HEC23404). Findings will be disseminated as reports, presentations and peer-reviewed journal articles.

Durch die Covid-19-Pandemie hat sich die mentale Gesundheit weltweit verschlechtert. In diesem Zusammenhang ist ein Anstieg an Suizidraten nicht auszuschließen. Suizid-Präventions-Apps könnten den Patienten im Umgang mit Suizidalität helfen. Deshalb wurden Effekte von Suizid-Präventions-Apps auf das Auftreten und die Intensität von Suizidgedanken im Zuge einer Übersichtsarbeit erfasst. Dabei wurden quantitative Studien zu Smartphone-Apps mit dem Endpunkt Suizidgedanken eingeschlossen, die eine Sicherheitsplanfunktion aufwiesen. Vier relevante Studien wurden identifiziert, bei denen das Vorliegen von Bias-Varianten unterschiedlicher Ausprägung angenommen werden muss. Die Ergebnisse zeigten zwar positive Effekte, die aber überwiegend statistisch nicht signifikant waren. Die Ergebnisse dieser Arbeit reihen sich in den bisherigen Stand der Forschung ein. Die geringe Zahl an Studien sowie methodische Schwachstellen limitieren die Aussagekraft der Ergebnisse. Deutschland ist in der Forschung und Entwicklung zu Suizid-Präventions-Apps kaum vertreten. Wenn zukünftig entsprechende internationale Apps als digitale Gesundheitsanwendungen (DiGAs) für das deutsche Gesundheitswesen verfügbar werden, ist davon auszugehen, dass eine Suizidprävention per App positive Effekte bei Suizidalität zeigen werden. Gleichzeitig sollten hochwertige Studien im nationalen Setting die positiven Versorgungseffekte zeitnah bestätigen.